Minerva Neurosciences, Inc.

DB:4MNA Stock Report

Market Cap: €10.5m

Minerva Neurosciences Management

Management criteria checks 3/4

Minerva Neurosciences' CEO is Remy Luthringer, appointed in Nov 2014, has a tenure of 10.5 years. total yearly compensation is $1.21M, comprised of 53.6% salary and 46.4% bonuses, including company stock and options. directly owns 2.64% of the company’s shares, worth €277.59K. The average tenure of the management team and the board of directors is 10.1 years and 10 years respectively.

Key information

Remy Luthringer

Chief executive officer

US$1.2m

Total compensation

CEO salary percentage53.6%
CEO tenure10.5yrs
CEO ownership2.6%
Management average tenure10.1yrs
Board average tenure10yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Remy Luthringer's remuneration changed compared to Minerva Neurosciences's earnings?
DateTotal CompensationSalaryCompany Earnings
Dec 31 2024US$1mUS$649k

US$1m

Sep 30 2024n/an/a

-US$3m

Jun 30 2024n/an/a

-US$34m

Mar 31 2024n/an/a

-US$32m

Dec 31 2023US$2mUS$624k

-US$30m

Sep 30 2023n/an/a

-US$28m

Jun 30 2023n/an/a

-US$27m

Mar 31 2023n/an/a

-US$29m

Dec 31 2022US$1mUS$600k

-US$32m

Sep 30 2022n/an/a

-US$47m

Jun 30 2022n/an/a

-US$49m

Mar 31 2022n/an/a

-US$51m

Dec 31 2021US$1mUS$585k

-US$50m

Sep 30 2021n/an/a

-US$36m

Jun 30 2021n/an/a

-US$35m

Mar 31 2021n/an/a

US$5m

Dec 31 2020US$2mUS$565k

US$2m

Sep 30 2020n/an/a

-US$21m

Jun 30 2020n/an/a

-US$27m

Mar 31 2020n/an/a

-US$69m

Dec 31 2019US$1mUS$543k

-US$72m

Sep 30 2019n/an/a

-US$55m

Jun 30 2019n/an/a

-US$54m

Mar 31 2019n/an/a

-US$54m

Dec 31 2018US$4mUS$525k

-US$50m

Compensation vs Market: Remy's total compensation ($USD1.21M) is above average for companies of similar size in the German market ($USD496.48K).

Compensation vs Earnings: Remy's compensation has been consistent with company performance over the past year.

CEO

Remy Luthringer (63 yo)

10.5yrs

Tenure

US$1,209,984

Compensation

Dr. Remy Luthringer, Ph D., serves as a Clinical Advisor to the Medicxi investment team and a Member of the Co-Founding team at Medicxi Ventures (UK) LLP. He has played an active role in several Index Vent...

Leadership Team

NamePositionTenureCompensationOwnership
Remy Luthringer
Executive Chairman & CEO10.5yrsUS$1.21m2.64%
€ 277.6k
Geoffrey Race
President3.6yrsUS$919.73k0.73%
€ 77.1k
Frederick Ahlholm
Senior VP10.8yrsUS$754.16k0.25%
€ 26.3k
Joseph Reilly
Senior VP & COO10.8yrsUS$1.49mno data
William Boni
Vice President of Investor Relations & Corporate Communications9.8yrsno datano data
Michael Davidson
Chief Medical Officer8.4yrsUS$657.47kno data

10.1yrs

Average Tenure

63.5yo

Average Age

Experienced Management: 4MNA's management team is seasoned and experienced (10.1 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Remy Luthringer
Executive Chairman & CEO10.5yrsUS$1.21m2.64%
€ 277.6k
G. van Heek
Independent Director10.8yrsUS$67.50k0.036%
€ 3.8k
Hans Hasler
Independent Director7.4yrsUS$75.63k0.018%
€ 1.9k
David Kupfer
Lead Independent Director9.5yrsUS$84.00k0.34%
€ 36.0k
Fouzia Laghrissi-Thode
Independent Director10yrsUS$70.13k0%
€ 0

10.0yrs

Average Tenure

68yo

Average Age

Experienced Board: 4MNA's board of directors are seasoned and experienced ( 10 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/05/05 18:26
End of Day Share Price 2025/05/05 00:00
Earnings2024/12/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Minerva Neurosciences, Inc. is covered by 5 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Brian SkorneyBaird
Jason ButlerCitizens JMP Securities, LLC
Douglas TsaoH.C. Wainwright & Co.